The impact of privacy and confidentiality laws on the conduct of clinical trials
暂无分享,去创建一个
Lawrence H. Muhlbaier | L. Muhlbaier | J. Armitage | L. Friedman | Jane Armitage | L. Hilbrich | Robert Souhami | Lawrence Friedman | Lutz Hilbrich | Jack Holland | Jane Shannon | Alison Van Nie | R. Souhami | A. V. Van Nie | Jack Holland | Jane Shannon | Lutz Hilbrich
[1] S. Yusuf. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial. Commentary , 2002 .
[2] R. Collins,et al. Study of the effectiveness of additional reductions in cholesterol and homocysteine (SEARCH): characteristics of a randomized trial among 12064 myocardial infarction survivors. , 2007, American heart journal.
[3] Karim Keshavjee,et al. Patients' consent preferences for research uses of information in electronic medical records: interview and survey data , 2003, BMJ : British Medical Journal.
[4] P. F. Kauff. Group , 2000, Elegant Design.
[5] W. Lowrance,et al. Learning from experience: privacy and the secondary use of data in health research. , 2003, Journal of health services research & policy.
[6] M. Coleman,et al. National survey of British public's views on use of identifiable medical data by the National Cancer Registry , 2006, BMJ : British Medical Journal.
[7] AndrewJ. S. Coats. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial , 2002, The Lancet.